Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-251,234
Closed -$12.1M 99
2025
Q2
$12.1M Sell
251,234
-199,194
-44% -$10.2M 1.09% 35
2025
Q1
$25M Buy
450,428
+194,711
+76% +$10.5M 2.3% 8
2024
Q4
$12.3M Buy
255,717
+33,394
+15% +$1.7M 1.4% 16
2024
Q3
$12.8M Buy
222,323
+11,226
+5% +$606K 0.9% 24
2024
Q2
$10.2M Buy
211,097
+13,284
+7% +$641K 1.27% 29
2024
Q1
$9.61M Buy
197,813
+117,429
+146% +$5.73M 0.87% 37
2023
Q4
$4M Sell
80,384
-4,570
-5% -$223K 0.48% 55
2023
Q3
$4.56M Buy
84,954
+15,337
+22% +$818K 0.49% 46
2023
Q2
$3.75M Sell
69,617
-19,570
-22% -$1.05M 0.68% 44
2023
Q1
$4.85M Buy
89,187
+16,746
+23% +$815K 0.67% 40
2022
Q4
$3.51M Buy
72,441
+15,485
+27% +$680K 0.53% 50
2022
Q3
$2.17M Buy
56,956
+10,998
+24% +$490K 0.33% 70
2022
Q2
$2.3M Buy
+45,958
New +$2.44M 0.41% 63
2021
Q4
Sell
-88,944
Closed -$4.29M 136
2021
Q3
$4.29M Buy
88,944
+4,794
+6% +$244K 0.52% 56
2021
Q2
$4.43M Sell
84,150
-17,277
-17% -$902K 0.51% 57
2021
Q1
$5.02M Sell
101,427
-9,320
-8% -$448K 0.89% 43
2020
Q4
$5.38M Buy
110,747
+31,668
+40% +$1.56M 0.65% 48
2020
Q3
$5.75M Sell
79,079
-31,735
-29% -$1.63M 0.88% 37
2020
Q2
$5.66M Buy
110,814
+25,067
+29% +$1.22M 1.02% 30
2020
Q1
$3.75M Buy
+85,747
New +$4.1M 0.76% 44

Other funds holding SNY

Parkwood LLC's SNY Position: Q3 2025 in Review

Parkwood LLC sold out of Sanofi (SNY) in Q3 2025, closing a stake of 251,234 shares — an estimated $12.1M sold.

Parkwood LLC first reported a position in SNY in Q1 2020 and held it in 20 quarters. The position peaked at $25M in Q1 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • Parkwood LLC reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • Parkwood LLC sold 251,234 Sanofi shares in Q3 2025, an estimated $12.1M.
  • Parkwood LLC first reported a position in Sanofi in Q1 2020 and held it in 20 quarters.
  • Parkwood LLC's Sanofi position peaked at $25M in Q1 2025.
  • 712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Parkwood LLC's 13F filing for Q3 2025, filed 14 Nov 2025.